In the SOD1G93A transgenic mice and in pathological samples from human ALS patients, the expression level of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) is increased, which is associated with inflammation and axonal degeneration. Here, RIPK1 is linked to amyotrophic lateral sclerosis.